Navigation Links
Access Pharmaceuticals Presents New Data on ProLindac(TM) at the 2009 AACR Annual Meeting
Date:4/21/2009

- Data demonstrates that ProLindac should provide sustained tumor exposure to platinum and provides a mechanistic rationale for the low hematoxicity observed in the clinic -

DALLAS, April 21 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced today that its collaborators at Centre Rene Huguenin in France presented new preclinical data on its lead anticancer compound, ProLindac(TM), at the American Association for Cancer Research (AACR) Annual Meeting taking place April 18-22, 2009 at the Colorado Convention Center in Denver. The poster presentation entitled "DACH platinum (dach-Pt) release kinetics, ex-vivo and in vivo plasma protein binding and evaluation of red blood cell (RBC) partitioning of ProLindac, a novel DACH-Pt-bound biopolymer" was presented on Monday, April 20.

ProLindac is Access' novel polymer-based DACH platinum prodrug which has been shown to be active in a wide variety of solid tumors in both preclinical models and in human trials. Access recently announced positive results from the completed phase 2 monotherapy clinical study in recurrent ovarian cancer. The study reported in the 2009 AACR poster provides in vitro and ex-vivo data on the binding of ProLindac to blood components, and suggests a mechanistic rationale for ProLindac's favorable efficacy and safety profile.

"The data shows that ProLindac's polymer carrier is highly bound to circulating plasma proteins," stated David P. Nowotnik, Ph.D., Access' Senior Vice President, Research and Development. "As a result, we would expect ProLindac to provide sustained tumor exposure to platinum. In addition, there was little red blood cell accumulation, which could account for the lower level of hematological toxicities observed for ProLindac compared to others platinum species."

"We are grateful to our European collaborators for their ongoing studies, which continue to expan
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Insmed Announces Agreement With IDIS to Manage Expanded Access Programs for IPLEX(TM)
2. New organic material may speed Internet access
3. Biogenerics Legislation Provides Critical Pathway to Affordable Access for Patients with Chronic and Complex Conditions
4. GPhA Statement on the Introduction of the Bipartisan Biogenerics Consensus Bill: Promoting Innovation and Access to Life-Saving Medicine Act
5. Sigma-Aldrich Streamlines Access to Advanced Stem Cell Research Portfolio and Opens Stem Cell Biology Community Through New Web Portal
6. Campbell Alliance Brand Management Practice to Present at EyeForPharmas Oncology Summit USA and Oncology Market Access Europe Conference
7. Schering-Plough Announces Collaboration With World Health Organization to Provide Access to Pandemic Influenza Vaccine Technology to Developing Countries
8. London-Based Double Helix Consulting Launches US Division for Strategic Pricing, Reimbursement and Market Access Solutions
9. Amgens Breakaway from Cancer Initiative Expands to Help Cancer Patients Access Broad Spectrum of Cancer Resources and Services
10. SurgiQuest Signs a Development and Supply Agreement with Intuitive Surgical for MIS Access Utilizing the AirSeal(TM) Technology
11. Jatropha World 2009 Advance Access: Surprisingly Candid Interview Series Examines Biofuel Predictions Compared to Fossil Fuels

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009).../--BlueMarbleEnergyCorp.announcedtodaythatthecompa...recentlyawarded$2millionbyWashingtonState,sCommuni...icpartnershiptoconstructthestate,sfirstspecialtybi...sinvestmentwillsignificantlyspeedthedevelopmentofo...y,"saidBlueMarbleEnergyCEOKellyOgilvie."Wearegrate...
(Date:11/24/2009)...ire-FirstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),...nnouncedthatithassubmittedaMAAtotheEuropeanMedicin...placementtherapyindevelopment,forthetreatmentofTyp...onforvelaglucerasealfathathasbeensubmitted,withpre..., Basedonaglobalsupplyshortageofthecurrentlyapprov...
(Date:11/24/2009)... Connects Customers with Partners Validated to Pro...k Products , Ottawa, ON (...ng provider of products for biological sample coll...nced its new global partner program. The program o...artner community and is designed to help partners ...
(Date:11/23/2009)...of it as origami very high-tech origami. , Resea...d a technique for fabricating three-dimensional, s...ms by coupling photolithography and a self-folding...films, only a few microns thick, offer mechanical ...es of the same material. , "This is a completely ...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Water droplets direct self-assembly process in thin-film materials 2
..., Sept. 27 ADVENTRX Pharmaceuticals,Inc. (Amex: ...t company,focused on commercializing proprietary p...infectious diseases, announced today that data fro...on) will be presented at,the American Association ...te (NCI) and European Organization and Treatment o...
..., N.Y., Sept. 26 The National,Alliance for Thromb...award,of two major program grants totaling $1.35 m...efforts to curb the unchecked devastating effects,...ho develop a blood clot. NATT will use its two Ce...nts to "launch a national wake-up call to promote ...
...DGE, MA -- Researchers from MIT, Alnylam Pharmaceu...e safety of a promising type of genetic therapy th...seases such as cancer. , The work, which will be ...es a new approach to conducting the therapy. A pap...nly used approach caused fatalities in mice. , Th...
Other Biology Technology:ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference 2ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference 3ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference 4CDC Awards NATT Funding to Improve Blood Clot Awareness 2CDC Awards NATT Funding to Improve Blood Clot Awareness 3Team demos safety of RNA therapy 2
(Date:11/23/2009)...2009 - The time of day matters to forest trees dea...ed by a research team led by Professor Malcolm Cam...incipal for research and colleagues in the departm...campus. , Capitalizing on their previous work ...rch team examined how poplar trees use their 45,00...
(Date:11/23/2009)...han 160 participants gathered this week for the se...ATIVE conference. This year,s topic, "Synthetic Bi...d medical researchers to explore the engineering, ...ging field of synthetic biology. , Bonnie L. Bas...University and this year,s conference chair, chall...
(Date:11/23/2009)... study provides "incontrovertible evidence" that t...f Sumatra about 73,000 years ago deforested much o...er, researchers report. , The volcano ejected an...mosphere, leaving a crater (now the world,s larges...5 kilometers wide. Ash from the event has been fou...
Breaking Biology News(10 mins):Time of day matters to thirsty trees, U of T researcher discovers 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Energy consumption makes Spanish forestry unsustainable 9887 1Energy consumption makes Spanish forestry unsustainable 9887 2American Society for Microbiology to launch new open access journal 9885 1American Society for Microbiology to launch new open access journal 9885 2SCAN Health Plan CEO Tom Lescault Hosts Biweekly Senior Focus Show on KOY 1230AM Seeks Input from Area Seniors 56937 1SCAN Health Plan CEO Tom Lescault Hosts Biweekly Senior Focus Show on KOY 1230AM Seeks Input from Area Seniors 56937 2
...he University of Colorado at Boulder reveals that ... a large source of fine, organic particle pollutan...ity over the Los Angeles region. , According to t...e than was previously thought is directly emitted ...percent of fine, organic particle pollutants form ...
...2008) Self-guided treatment for depression could ...th the National Space Biomedical Research Institut...ia program that will assist astronauts in recogniz...psychosocial problems, which can pose a substantia...ing long-duration spaceflights. , Even though th...
...ailable in German . , Dessau. Extreme flood e...les and molluscs more than plants. This is the fin...entre for Environmental Research (UFZ), TU Berlin,...KON Kallmnz and the ILN Bhl, following several yea...s of August 2002. Flow variations are known to be ...
Other Biology News:CU-Boulder study suggests air quality regulations miss key pollutants 2Coming soon: Self-guided, computer-based depression treatment 2Coming soon: Self-guided, computer-based depression treatment 3Vegetation hardly affected by extreme flood events 2
Madin-Darby bovine kidney (MDBK) cells from Exalpha Biologicals, Inc.
... Gene Construction KitTM allows graphic manipulati...ing options. It has an award winning interface des...ces in addition to providing sophisticated drawing...amed the "Best Plasmid Mapping Software" by the Bi...
Rabbit Anti-Human Prolactin Releasing Hormone Receptor (GPR10) Polyclonal Antibody, Unconjugated from IMGENEX
Rabbit Anti-Rat Sphingolipid Receptor Edg8 / S1P5 Polyclonal Antibody, Unconjugated from IMGENEX
Biology Products: